Contemporary Oral Oncology

Oral Carcinogenesis.- Biologic Basis of Personalized Therapy in Oral Cancer.- Etiology of Oral Cancer.- Human Papilloma Virus.- Epidemiology of Oral Cancer.- Histopathology Malignant and Premalignant Oral Cavity Neoplasms.- Screening for Oral Cavity Cancer.- Advances in Early Detection and Diagnostic Adjuncts in  Oral Cavity Cancer.- Oral Submucous Fibrosis.- Oral Potentially Maglignant Lesions: Classification and Comprehensive Management.

Moni Abraham Kuriakose, BSc, BDS, MB ChB, MD, FDSRCS, FFDRCS, FRCS Ed, FRCS (Maxillofacial Surgery), is Director of the Translational Research Program and Attending Surgeon in the Department of Head and Neck/Plastic and Reconstructive Surgery at the Roswell Park Cancer Institute, Buffalo, New York, and Professor of Surgery, Director of the Department of Surgical Oncology, and Chief of the Division of Head and Neck Oncology at the Mazumdar-Shaw Cancer Center, Narayana Health City, Bangalore, India. In addition, he is Adjunct Associate Professor in the Departments of Oral and Maxillofacial Surgery and Otolaryngology at New York University. Dr. Kuriakose has received numerous honors and awards and has held many national and international leadership positions, including as Chairman of the Oral Cancer Special Interest Group, International Association of Oral and Maxillofacial Surgeons (2008-2012), Secretary General of the International Academy of Oral Oncology (2013-2015) and President of Indian Head and Neck Oncology Society (2015-2017). He is a member of the editorial boards for Oral Oncology and the Journal of Maxillofacial and Oral Surgery, and a reviewer for a number of other leading journals. Dr. Kuriakose's research group focuses on two key challenges: down-staging and prevention of oral cancer; and reversing chemotherapy resistance. He has been the principal investigator on many research projects and is the author of over 150 peer-reviewed publications.